Abstract
This guideline provides recommendations to users and manufacturers of point-of-care coagulation testing devices for monitoring heparin and vitamin K antagonist therapy and for the evaluation of hemostasis, as well as to ensure reliable results comparable with those obtained by routine medical laboratory testing.
| Original language | English (US) |
|---|---|
| Publisher | CLSI |
| ISBN (Electronic) | 978-1-68440-087-4 |
| ISBN (Print) | 978-1-68440-086-7 |
| State | Published - Jul 27 2020 |